PC
UTHR icon

Polar Capital’s United Therapeutics UTHR Stock Holding History

Polar Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$562K Buy
5,565
+2,990
+116% +$328K ﹤0.01% 273
2020
Q2 		$312K Buy
+2,575
New +$290K ﹤0.01% 263

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Polar Capital's UTHR Position: Q3 2020 in Review

Polar Capital increased its United Therapeutics (UTHR) stake by 116% in Q3 2020, buying an estimated $328K and bringing the position to 5,565 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

Polar Capital first reported a position in UTHR in Q2 2020 and has held it in 2 quarters since. 333 funds tracked by Wall St. Rank hold UTHR as of Q3 2020.

  • Polar Capital held 5,565 shares of United Therapeutics worth $562K as of Q3 2020.
  • Polar Capital bought 2,990 United Therapeutics shares in Q3 2020, an estimated $328K.
  • United Therapeutics made up ﹤0.01% of Polar Capital's portfolio in Q3 2020, its #273 holding.
  • Polar Capital first reported a position in United Therapeutics in Q2 2020 and has held it in 2 quarters since.
  • 333 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.